Perforating calcific elastosis
(Redirected from Localized acquired cutaneous pseudoxanthoma elasticum)
Perforating calcific elastosis is a rare skin condition characterized by the deposition of calcium in the skin's elastic fibers, leading to their perforation. It is often associated with kidney disease, particularly in patients undergoing dialysis.
Symptoms[edit | edit source]
The primary symptom of perforating calcific elastosis is the appearance of small, white, firm papules on the skin. These papules are typically found on the extremities, particularly the hands and feet. They may be asymptomatic or cause mild itching.
Causes[edit | edit source]
The exact cause of perforating calcific elastosis is unknown. However, it is often associated with chronic kidney disease and dialysis. The condition is thought to result from an imbalance in calcium and phosphate metabolism, leading to the deposition of calcium in the skin's elastic fibers.
Diagnosis[edit | edit source]
Diagnosis of perforating calcific elastosis is typically made through a skin biopsy. Under the microscope, the skin shows characteristic changes, including the presence of calcium deposits in the elastic fibers and their perforation.
Treatment[edit | edit source]
There is no specific treatment for perforating calcific elastosis. Management is primarily aimed at controlling the underlying kidney disease and maintaining a balance in calcium and phosphate levels. Topical steroids and emollients may be used to manage the skin symptoms.
See also[edit | edit source]
Perforating calcific elastosis Resources | ||
---|---|---|
|
|
References[edit | edit source]
External links[edit | edit source]
- Perforating calcific elastosis in a patient on chronic dialysis: a case report and review of the literature
- Perforating calcific elastosis: a review of the literature
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD